Science 37 Holdings, Inc. (SNCE)

NASDAQ: SNCE · IEX Real-Time Price · USD
0.407
+0.036 (9.65%)
At close: Sep 22, 2023, 4:00 PM
0.410
+0.003 (0.79%)
After-hours: Sep 22, 2023, 7:26 PM EDT
9.65%
Market Cap 47.64M
Revenue (ttm) 61.62M
Net Income (ttm) -134.26M
Shares Out 117.11M
EPS (ttm) -1.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 542,310
Open 0.360
Previous Close 0.371
Day's Range 0.360 - 0.410
52-Week Range 0.190 - 1.990
Beta 1.30
Analysts Buy
Price Target 2.00 (+391.64%)
Earnings Date Nov 9, 2023

About SNCE

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support v... [Read more]

Sector Healthcare
Founded 2014
Employees 460
Stock Exchange NASDAQ
Ticker Symbol SNCE
Full Company Profile

Financial Performance

In 2022, Science 37's revenue was $70.15 million, an increase of 17.70% compared to the previous year's $59.60 million. Losses were -$50.99 million, -45.95% less than in 2021.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for SNCE stock is "Buy." The 12-month stock price forecast is $2.0, which is an increase of 391.64% from the latest price.

Price Target
$2.0
(391.64% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List

RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that its Chief Delivery Off...

3 days ago - GlobeNewsWire

Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023

RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Science 37 announced today that it has been recognized in the Gartner Hype Cycle for Life Science Clinical Development, 2023. As stated...

10 days ago - GlobeNewsWire

Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan

RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that it has been honored wi...

11 days ago - GlobeNewsWire

Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upco...

18 days ago - GlobeNewsWire

Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards

RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ is proud to announce its nomination for the p...

5 weeks ago - GlobeNewsWire

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2023 (GLOBE NEWSWIRE) -- August 11, 2023—Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equ...

6 weeks ago - GlobeNewsWire

Science 37 Reports Second Quarter 2023 Financial Results

RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the q...

6 weeks ago - GlobeNewsWire

Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023

RESEARCH TRIANGLE PARK, N.C., July 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report second quarter 2023 financial re...

2 months ago - GlobeNewsWire

Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)

Science 37's Metasite to Facilitate Phase 3 Study Enrollment by Expanding Access and Maximizing Convenience for Patients Science 37's Metasite to Facilitate Phase 3 Study Enrollment by Expanding Acces...

2 months ago - GlobeNewsWire

Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"

Science 37's unified platform that powers the Metasite receives award for outstanding digital health and technology innovation Science 37's unified platform that powers the Metasite receives award for...

4 months ago - GlobeNewsWire

Science 37 Reports First Quarter 2023 Financial Results

RESEARCH TRIANGLE PARK, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the qu...

4 months ago - GlobeNewsWire

Science 37 Joins Partnership in Support of White House CancerX and Cancer Moonshot

Strategic partnership will leverage Science 37's leadership in remote and hybrid clinical research to enable expansive clinical trial access for oncology patients Strategic partnership will leverage S...

5 months ago - GlobeNewsWire

Science 37 to Report First Quarter 2023 Financial Results on May 15, 2023

RESEARCH TRIANGLE PARK, N.C., May 01, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report first quarter 2023 financial resu...

5 months ago - GlobeNewsWire

Science 37 Appoints SVP, Erica Prowisor, to Bolster Patient Recruitment Velocity, Diversity

New role supports the Company's objective to lead the industry with faster, more inclusive clinical research New role supports the Company's objective to lead the industry with faster, more inclusive ...

5 months ago - GlobeNewsWire

Science 37 Adds New Head of Quality, Irena Lambridis

New role supports the Company's objective to be the DCT industry's “undisputed leader” in quality New role supports the Company's objective to be the DCT industry's “undisputed leader” in quality

5 months ago - GlobeNewsWire

Science 37 to Host Business Update Call on April 12, 2023

RESEARCH TRIANGLE PARK, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will host a business update conference call...

5 months ago - GlobeNewsWire

Science 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and Quality

Centers of Excellence to strengthen and scale the company's Metasite offering and accelerate its path to profitability Centers of Excellence to strengthen and scale the company's Metasite offering and...

5 months ago - GlobeNewsWire

Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results

RESEARCH TRIANGLE PARK, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the ...

7 months ago - GlobeNewsWire

Science 37 to Present at the Cowen 43rd Annual Health Care Conference

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcom...

7 months ago - GlobeNewsWire

Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023

RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report fourth quarter 2022 financial re...

7 months ago - GlobeNewsWire

Science 37 Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under...

8 months ago - GlobeNewsWire

Science 37 Acquires Vault Health's Life Sciences Platform To Bolster its Metasite Capabilities

RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite, announced today that it has acquired the life sciences platform...

8 months ago - GlobeNewsWire

Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference

RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upco...

10 months ago - GlobeNewsWire

Science 37 and BEKHealth Collaborate to Expand Patient Access Via Community Providers

The partnership will enable Science 37 to directly access electronic medical record (EMR) data to find and match patients to clinical trials across its expanding community provider network, covering m...

10 months ago - GlobeNewsWire

Science 37 and Linical Announce Partnership to Enable Fully Decentralized and Hybrid Trials

As a certified partner, Linical will leverage Science 37's Metasite™ to provide global access to patients beyond its existing brick-and-mortar site network As a certified partner, Linical will leverag...

11 months ago - GlobeNewsWire